Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Cameroni

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Nature Communications|December 10, 2017
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniaeMeghan E Pennini, Anna De Marco, Mark Pelletier, et al.
The Lancet Regional Health. Europe|June 26, 2021
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern SwitzerlandLuca Piccoli, Paolo Ferrari, Giovanni Piumatti, et al.
Science (New York, N.Y.)|July 16, 2016
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionKarin Stettler, Martina Beltramello, Diego A Espinosa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Antibody-based assay discriminates Zika virus infection from other flavivirusesAngel Balmaseda, Karin Stettler, Raquel Medialdea-Carrera, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccinesJohn E Bowen, Kaitlin R Sprouse, Alexandra C Walls, et al.
AIDS Research and Human Retroviruses|August 6, 2024
PET/CT Targeted Tissue Sampling Reveals Intravenously Administered HGN194 IgG1 Affects HIV Distribution after Rectal ExposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature|August 31, 2021
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodiesFlorian A Lempp, Leah B Soriaga, Martin Montiel-Ruiz, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Nature Communications|December 10, 2017
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniaeMeghan E Pennini, Anna De Marco, Mark Pelletier, et al.
The Lancet Regional Health. Europe|June 26, 2021
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern SwitzerlandLuca Piccoli, Paolo Ferrari, Giovanni Piumatti, et al.
Science (New York, N.Y.)|July 16, 2016
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionKarin Stettler, Martina Beltramello, Diego A Espinosa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Antibody-based assay discriminates Zika virus infection from other flavivirusesAngel Balmaseda, Karin Stettler, Raquel Medialdea-Carrera, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccinesJohn E Bowen, Kaitlin R Sprouse, Alexandra C Walls, et al.
AIDS Research and Human Retroviruses|August 6, 2024
PET/CT Targeted Tissue Sampling Reveals Intravenously Administered HGN194 IgG1 Affects HIV Distribution after Rectal ExposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature|August 31, 2021
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodiesFlorian A Lempp, Leah B Soriaga, Martin Montiel-Ruiz, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Pageof 7